Filing Details
- Accession Number:
- 0001235802-11-000025
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-01-21 12:00:00
- Reporting Period:
- 2011-01-21
- Filing Date:
- 2011-01-21
- Accepted Time:
- 2011-01-21 12:21:12
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1023024 | Biosante Pharmaceuticals Inc | BPAX | Biological Products, (No Disgnostic Substances) (2836) | 582301143 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1238120 | B Philip Donenberg | 111 Barclay Blvd Suite 280 Lincolnshire IL 60069 | Sr. Vp Of Finance, Cfo & Sec'y | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2011-01-21 | 1,000 | $1.88 | 42,322 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
